328 related articles for article (PubMed ID: 17544803)
21. Anti-phagocytic mechanisms of Streptococcus pyogenes: binding of fibrinogen to M-related protein.
Courtney HS; Hasty DL; Dale JB
Mol Microbiol; 2006 Feb; 59(3):936-47. PubMed ID: 16420362
[TBL] [Abstract][Full Text] [Related]
22. Immune response to superoxide dismutase in group A streptococcal infection.
McMillan DJ; Davies MR; Good MF; Sriprakash KS
FEMS Immunol Med Microbiol; 2004 Apr; 40(3):249-56. PubMed ID: 15039102
[TBL] [Abstract][Full Text] [Related]
23. Hyaluronic acid capsule modulates M protein-mediated adherence and acts as a ligand for attachment of group A Streptococcus to CD44 on human keratinocytes.
Schrager HM; Albertí S; Cywes C; Dougherty GJ; Wessels MR
J Clin Invest; 1998 Apr; 101(8):1708-16. PubMed ID: 9541502
[TBL] [Abstract][Full Text] [Related]
24. Variable susceptibility to opsonophagocytosis of group A streptococcus M-1 strains by human immune sera.
Villaseñor-Sierra A; McShan WM; Salmi D; Kaplan EL; Johnson DR; Stevens DL
J Infect Dis; 1999 Dec; 180(6):1921-8. PubMed ID: 10558949
[TBL] [Abstract][Full Text] [Related]
25. Transcription of the Streptococcus pyogenes hyaluronic acid capsule biosynthesis operon is regulated by previously unknown upstream elements.
Falaleeva M; Zurek OW; Watkins RL; Reed RW; Ali H; Sumby P; Voyich JM; Korotkova N
Infect Immun; 2014 Dec; 82(12):5293-307. PubMed ID: 25287924
[TBL] [Abstract][Full Text] [Related]
26. Targeted amino acid substitutions impair streptolysin O toxicity and group A Streptococcus virulence.
Chiarot E; Faralla C; Chiappini N; Tuscano G; Falugi F; Gambellini G; Taddei A; Capo S; Cartocci E; Veggi D; Corrado A; Mangiavacchi S; Tavarini S; Scarselli M; Janulczyk R; Grandi G; Margarit I; Bensi G
mBio; 2013 Jan; 4(1):e00387-12. PubMed ID: 23300245
[TBL] [Abstract][Full Text] [Related]
27. Antibodies against four proteins from a Streptococcus pyogenes serotype M1 strain and levels of circulating mannan-binding lectin in acute poststreptococcal glomerulonephritis.
Skattum L; Akesson P; Truedsson L; Sjöholm AG
Int Arch Allergy Immunol; 2006; 140(1):9-19. PubMed ID: 16508336
[TBL] [Abstract][Full Text] [Related]
28. A novel bacterial resistance mechanism against human group IIA-secreted phospholipase A2: role of Streptococcus pyogenes sortase A.
Movert E; Wu Y; Lambeau G; Touqui L; Areschoug T
J Immunol; 2011 Dec; 187(12):6437-46. PubMed ID: 22075700
[TBL] [Abstract][Full Text] [Related]
29. Inactivation of the cysteine protease SpeB affects hyaluronic acid capsule expression in group A streptococci.
Woischnik M; Buttaro BA; Podbielski A
Microb Pathog; 2000 Apr; 28(4):221-6. PubMed ID: 10764613
[TBL] [Abstract][Full Text] [Related]
30. Multivalent group A streptococcal vaccine designed to optimize the immunogenicity of six tandem M protein fragments.
Dale JB
Vaccine; 1999 Jan; 17(2):193-200. PubMed ID: 9987154
[TBL] [Abstract][Full Text] [Related]
31. Interaction between complement regulators and Streptococcus pyogenes: binding of C4b-binding protein and factor H/factor H-like protein 1 to M18 strains involves two different cell surface molecules.
Pérez-Caballero D; García-Laorden I; Cortés G; Wessels MR; de Córdoba SR; Albertí S
J Immunol; 2004 Dec; 173(11):6899-904. PubMed ID: 15557185
[TBL] [Abstract][Full Text] [Related]
32. Factor H binds to the hypervariable region of many Streptococcus pyogenes M proteins but does not promote phagocytosis resistance or acute virulence.
Gustafsson MC; Lannergård J; Nilsson OR; Kristensen BM; Olsen JE; Harris CL; Ufret-Vincenty RL; Stålhammar-Carlemalm M; Lindahl G
PLoS Pathog; 2013; 9(4):e1003323. PubMed ID: 23637608
[TBL] [Abstract][Full Text] [Related]
33. Analysis of the coverage capacity of the StreptInCor candidate vaccine against Streptococcus pyogenes.
De Amicis KM; Freschi de Barros S; Alencar RE; Postól E; Martins Cde O; Arcuri HA; Goulart C; Kalil J; Guilherme L
Vaccine; 2014 Jul; 32(32):4104-10. PubMed ID: 23994376
[TBL] [Abstract][Full Text] [Related]
34. Human disease isolates of serotype m4 and m22 group a streptococcus lack genes required for hyaluronic acid capsule biosynthesis.
Flores AR; Jewell BE; Fittipaldi N; Beres SB; Musser JM
mBio; 2012 Nov; 3(6):e00413-12. PubMed ID: 23131832
[TBL] [Abstract][Full Text] [Related]
35. Ig-binding surface proteins of Streptococcus pyogenes also bind human C4b-binding protein (C4BP), a regulatory component of the complement system.
Thern A; Stenberg L; Dahlbäck B; Lindahl G
J Immunol; 1995 Jan; 154(1):375-86. PubMed ID: 7995956
[TBL] [Abstract][Full Text] [Related]
36. Regulation of protein H expression in M1 serotype isolates of Streptococcus pyogenes.
Smith TC; Sledjeski DD; Boyle MD
FEMS Microbiol Lett; 2003 Feb; 219(1):9-15. PubMed ID: 12594016
[TBL] [Abstract][Full Text] [Related]
37. Stimulation of long-lasting protection against Streptococcus pyogenes after intranasal vaccination with non adjuvanted fibronectin-binding domain of the SfbI protein.
Schulze K; Medina E; Chhatwal GS; Guzmán CA
Vaccine; 2003 May; 21(17-18):1958-64. PubMed ID: 12706684
[TBL] [Abstract][Full Text] [Related]
38. Hyaluronic acid capsule is a virulence factor for mucoid group A streptococci.
Wessels MR; Moses AE; Goldberg JB; DiCesare TJ
Proc Natl Acad Sci U S A; 1991 Oct; 88(19):8317-21. PubMed ID: 1656437
[TBL] [Abstract][Full Text] [Related]
39. Human IgG Increases Virulence of
Ermert D; Weckel A; Magda M; Mörgelin M; Shaughnessy J; Rice PA; Björck L; Ram S; Blom AM
J Immunol; 2018 May; 200(10):3495-3505. PubMed ID: 29626087
[No Abstract] [Full Text] [Related]
40. Oxygen-dependent phenotypic variation in group A streptococcus.
Chiang-Ni C; Nian SY; Wu JJ; Chen CJ
J Microbiol Immunol Infect; 2016 Dec; 49(6):837-842. PubMed ID: 25649484
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
